New Research Identifies Critical Lipoprotein(a) Threshold for Heightened Risk of Stroke and Cardiac Death

New data from 20,000 NIH trial participants identifies 175 nmo/L as the threshold for significantly higher cardiovascular death and stroke risk.

By: AXL Media

Published: Apr 25, 2026, 9:05 AM EDT

Source: Information for this report was sourced from EurekAlert!

Pinpointing the Genetic Culprit Behind Unexplained Cardiac Events

Groundbreaking data released at the SCAI 2026 Scientific Sessions in Montreal has shed new light on the role of Lipoprotein(a), a largely inherited particle that contributes to heart disease. Unlike common low-density lipoprotein, this specific particle carries an additional protein that intensifies its impact on the cardiovascular system. Researchers revealed that approximately 20 percent of the global population carries high levels of this particle, yet a vast majority remains unaware of their status due to a lack of routine screening and visible symptoms.

Revisiting Historical NIH Trial Data for Modern Insights

The study involved a comprehensive re-evaluation of plasma samples from three landmark National Institutes of Health trials, the ACCORD, PEACE, and SPRINT studies. By analyzing biospecimens from 20,070 participants aged 40 and older, scientists were able to apply modern, standardized assays to measure Lipoprotein(a) in nanomoles per liter. This retrospective approach allowed for a robust longitudinal analysis, following participants over a median period of nearly four years to correlate specific particle concentrations with actual clinical outcomes.

Identifying the High Risk Threshold in Diverse Patient Groups

The clinical findings established that a Lipoprotein(a) level equal to or exceeding 175 nmo/L acts as a critical tipping point for patient safety. Individuals reaching this concentration were found to have a 31 percent higher risk of major adverse cardiovascular events. While the data did not show a direct link to increased heart attacks at this specific level, the association with stroke and cardiovascular death was strikingly significant, with the latter showing a 49 percent increase in likelihood compared to those with lower levels.